Stay updated on Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-19T21:52:48.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-13T04:23:13.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    - A new revision entry v3.7.0 appears in the study record history. The previous v3.6.6 entry is removed from the history list, indicating an update to the page's revision tracking.
    Difference
    0.1%
    Check dated 2026-09-21T22:22:09.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision: v3.6.6 is now shown, replacing Revision: v3.6.5. This signals a new build of the page rather than any substantive content change.
    Difference
    0.1%
    Check dated 2026-08-31T17:30:23.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    The page history now shows Revision: v3.6.5 instead of v3.6.4, indicating a small update to the study record history display/backend. The change does not modify study data or visible content beyond the version label.
    Difference
    0.1%
    Check dated 2026-08-10T13:23:24.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    The page shows a new site revision: v3.6.4, replacing v3.6.3. This indicates a small update to the site's interface/backend.
    Difference
    0.1%
    Check dated 2026-07-27T06:26:04.000Z thumbnail image

Stay in the know with updates to Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial page.